1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Recrudescence in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achiron, A; Biegon, A; Lavie, V; Margalit, R; Miron, S | 1 |
Crombag, H; De Vries, TJ; Dieben, J; Homberg, JR; Schoffelmeer, AN; Schuurman, K; Shaham, Y; Vanderschuren, LJ | 1 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Recrudescence
Article | Year |
---|---|
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
Topics: Acute Disease; Animals; Brain; Dose-Response Relationship, Drug; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Injections, Intraperitoneal; Injections, Intravenous; Multiple Sclerosis; Neuroprotective Agents; Rats; Rats, Inbred Lew; Recurrence; Spinal Cord; Time Factors; Treatment Outcome | 2000 |
A cannabinoid mechanism in relapse to cocaine seeking.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Modulators; Cannabinoids; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dronabinol; Humans; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Recurrence; Rimonabant | 2001 |